Outlook Therapeutics (OTLK) Income from Non-Controlling Interests (2015)
Outlook Therapeutics (OTLK) reported Income from Non-Controlling Interests of -$896136.0 for Q3 2015, down 135.56% quarter-over-quarter from -$380435.0 in Q2 2015.
Outlook Therapeutics (OTLK) Income from Non-Controlling Interests (2015) Analysis & Trends
Outlook Therapeutics (OTLK) has 1 years of Income from Non-Controlling Interests data on file, last reported at -$896136.0 in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -13.75 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | - |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Outlook Therapeutics | 51.13 Mn | 43.39 Mn | -21,888.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2015 | -896,136.00 |
| Jun 30, 2015 | -380,435.00 |